anx_I__cpt_7__cpt_2__cpt_2__table_1__row_2 — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16… · Lexiara

anx_I__cpt_7__cpt_2__cpt_2__table_1__row_2

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

The investigational medicinal product is authorised or has a marketing authorisation in an ICH country and is used in the clinical trial:

← anx_I__cpt_7__cpt_2__cpt_2__table_1__row_1__cell_4 · All articles · anx_I__cpt_7__cpt_2__cpt_2__table_1__row_2__cell_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.